Search results for "new drug development"

MSD Bets $510M on High-Quality Data to Fuel Post-Keytruda AI Drug Discovery

MSD Bets $510M on High-Quality Data to Fuel Post-Keytruda AI Drug Discovery

MSD, which has long dominated the global cancer market with its blockbuster immuno-oncology therapy Keytruda, is investing heavily in artificial...
New Hope for MASH: Researchers Uncover Key to Reversing Liver Fibrosis

New Hope for MASH: Researchers Uncover Key to Reversing Liver Fibrosis

Researchers have unveiled findings that raise hopes for a future where a single pill could safely and effectively treat metabolic steatohepatitis and...
Curocell’s Homegrown CAR-T Therapy Rimqarto Lands Spotlight in Top Hematology Journal Blood

Curocell’s Homegrown CAR-T Therapy Rimqarto Lands Spotlight in Top Hematology Journal Blood

Curocell, a South Korean clinical-stage biotech company specializing in chimeric antigen receptor T-cell (CAR-T)...
Amyloid Is Not the Only Culprit: GRK2 Protein Emerges as New Target in Alzheimer’s Fight

Amyloid Is Not the Only Culprit: GRK2 Protein Emerges as New Target in Alzheimer’s Fight

For decades, Alzheimer’s disease research has focused intensely on two primary culprits: beta-amyloid, which forms...
From Saliva to Gut: How Human Anatomy Differs from Dogs and Lions

From Saliva to Gut: How Human Anatomy Differs from Dogs and Lions

As discussed in last week’s column(*), the structure of the human mouth—including the jaw joint and teeth—more closely...
Unmasking Glioblastoma’s Accomplice: Researchers Identify Hidden Protein Network Driving Brain Tumor Recurrence

Unmasking Glioblastoma’s Accomplice: Researchers Identify Hidden Protein Network Driving Brain Tumor Recurrence

"I had surgery and I even went through radiation—so why did it come back?" Families of glioblastoma patients face this...
HK inno.N’s Obesity Drug Candidate Outperforms Wegovy in Head-to-Head Phase 2 Trial

HK inno.N’s Obesity Drug Candidate Outperforms Wegovy in Head-to-Head Phase 2 Trial

HK inno.N announced on June 9 that its obesity drug candidate, ecnoglutide, demonstrated superior weight-loss efficacy...
Will a 'Second Gleevec' Emerge? The Race Heats Up for Rare Gastrointestinal Cancer Breakthroughs

Will a 'Second Gleevec' Emerge? The Race Heats Up for Rare Gastrointestinal Cancer Breakthroughs

A rare cancer can form in the wall of the stomach or intestines: gastrointestinal stromal tumor, or GIST.
Complete Remission in Metastatic Pancreatic Cancer: Nesuparib Shows Early Clinical Promise

Complete Remission in Metastatic Pancreatic Cancer: Nesuparib Shows Early Clinical Promise

Early clinical data point to extended survival and the rare possibility of complete remission in metastatic pancreatic...
Ebola spreads rapidly in DRC—how far have new vaccines and treatments come?

Ebola spreads rapidly in DRC—how far have new vaccines and treatments come?

A Reuters report said the U.K. media outlet The Guardian reported on the 19th (20th in Korea time) that the World...